Trinity Hunt Partners, a growth-oriented private equity firm focused on services businesses, has made a majority investment in Centricity Research, a clinical research services provider specialising in conducting Phase I-IV clinical trials across more than 40 therapeutic areas.
Financial terms of the transaction have not been disclosed.
With over 35 locations across the United States and Canada, Centricity provides an array of trial types for pharmaceutical sponsors and contract research organisations (CROs) in the design and execution of clinical trials.
In partnership with Centricity’s management team, Trinity Hunt plans to expand the company’s capabilities and therapeutic coverage areas by investing in organic growth initiatives and acquiring complementary clinical research site businesses.
McGuireWoods served as legal advisor to Trinity Hunt.